concentration vs time curve; AUC i , area under the concentration vs time curve when co-administered with an inhibitor; AUCR, area under the plasma concentration-time curve ratio in the inhibited and control state; C max , maximum concentration values; C avg , average concentration values; C max,u , unbound maximum concentration values; C avg,u , unbound average concentration values; P450, cytochrome P450; CYP3A, cytochrome P450 3A4/5; DDI, drug-drug interaction; f u , fraction unbound; HHEP, human hepatocyte; HLM, human liver microsome; IC 50 , inhibitory concentration at 50%; [I], inhibitor concentration; [I] g , intestinal inhibitor concentration; [I] h , liver inhibitor concentration; K i , reversible inhibition constant; K I , time-dependent inhibition constant; k inact , maximal rate of enzyme inactivation; k obs , rate constant for inhibition; K p,uu ; unbound partition coefficient in hepatocyte; LC-MS/MS, liquid chromatography-tandem mass spectrometry; m/z, mass to charge ratio; PBPK, physiologically-based pharmacokinetic modeling; TDI, time-dependent inhibition; WEM, William's E medium.